JhaRPatelHDubeyR, et al.Clinical and molecular spectrum associated with polymerase-γ related disorders. J Child Neurol. 2022;37(4):246-255. doi:10.1177/08830738211067065
2.
SpracklenTFKasherPRKrausS, et al.Identification of a POLG variant in a family with arrhythmogenic cardiomyopathy and left ventricular fibrosis. Circ Genom Precis Med. 2021;14(1):e003138. doi:10.1161/CIRCGEN.120.003138
3.
Gurgel-GiannettiJCamargosSTCardosoFHiranoMDiMauroS. POLG1 Arg953cys mutation: expanded phenotype and recessive inheritance in a Brazilian family. Muscle Nerve. 2012;45(3):453-454. doi:10.1002/mus.22330
4.
DeschauerMTennantSRokickaA,et al.MELAS associated with mutations in the POLG1 gene. Neurology. 2007;68(20):1741-1742. doi:10.1212/01.wnl.0000261929.92478.3e
5.
LovanAHaqIuBalakrishnanN. Diagnostic challenges in movement disorders: sensory ataxia neuropathy dysarthria and ophthalmoplegia (SANDO) syndrome. BMJ Case Rep. 2013;2013(1):bcr2013010343. doi:10.1136/bcr-2013-010343
6.
FinstererJ. Liver pathology in hepato-cerebral mitochondrial depletion syndromes due to POLG1, DGUOK, 146or MPV17 variants. Pol J Pathol. 2019;70(2):146-147. doi:10.5114/pjp.2019.87107
7.
MartikainenMHPäivärintaMJääskeläinenSMajamaaK. Successful treatment of POLG-related mitochondrial epilepsy with antiepileptic drugs and low glycaemic index diet. Epileptic Disord. 2012;14(4):438-441. doi:10.1684/epd.2012.0543
